What does OMNIMED do?

OMNIMED is a pharmacy in Kalmthout. Public Limited, started on 4 June 1999, 2 establishments.

What is the address of OMNIMED?

The registered office of OMNIMED is located at Heidestatiestraat (Heide) 23 box 1, 2920 Kalmthout.

Is OMNIMED still active?

Yes. According to the CBE (30 October 2026) OMNIMED is active, legal situation “Normale toestand”, started on 4 June 1999.

Is OMNIMED registered on Peppol?

Yes, OMNIMED is registered on the Peppol network with ID 0208:0466165667.

What is the enterprise number of OMNIMED?

The enterprise number of OMNIMED is BE0466165667.

When was OMNIMED founded?

OMNIMED was founded on 4 June 1999.

Who are the directors of OMNIMED?

According to the 2025 annual accounts, the directors of OMNIMED are: Toon Verpraet BV.

Is OMNIMED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 June 1999; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did OMNIMED make in 2025?

OMNIMED posted a profit after taxes of € 318,941 in financial year 2025.

What is the revenue of OMNIMED?

As a small company, OMNIMED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,013,556.

How much does an employee at OMNIMED earn?

The average wage cost per full-time employee at OMNIMED was € 72,700 in 2025: staff costs of € 392,805 for 5.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does OMNIMED have?

According to the 2025 annual accounts, OMNIMED has 5.4 full-time equivalents (FTE).

OMNIMED (Public Limited) - Kalmthout - BE0466165667

Dossier OMNIMED, printed on 30 October 2026 from databakkes.be/en/0466165667/omnimed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

OMNIMED from Kalmthout, company number BE0466165667, closed financial year 2025 with a result of € 318,941 after tax. For that financial year OMNIMED recorded a gross margin of € 1 million and equity of € 944,432. Compared with financial year 2024, the result moved from € 209,606 to € 318,941. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.

What it is worth Growing

€ 944,432

▲ 51% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 318,941

▲ 52% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 461,853

▲ 41% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 882,432.

People and assets in 2025

Full-time equivalents

5.4

▲ 0.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 392,805

▲ 7% vs 2024

€ 72,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 9,266

▲ 237% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 682,420

▼ 17% vs 2024

€ 135,837 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 367,501

▲ 18% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 93,838

▲ 24% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 675,131 Gross margin 2022: € 675,131 First fiscal year in the series	€ 721,535 Gross margin 2023: € 721,535 ▲ 7% vs 2022 (€ 675,131) Favourable step	€ 830,364 Gross margin 2024: € 830,364 ▲ 15% vs 2023 (€ 721,535) Favourable step	€ 1,013,556 Gross margin 2025: € 1,013,556 ▲ 22% vs 2024 (€ 830,364) Favourable step	▲ 22%
Profit after taxes	€ 153,596 Profit after taxes 2022: € 153,596 First fiscal year in the series	€ 126,347 Profit after taxes 2023: € 126,347 ▼ 18% vs 2022 (€ 153,596) Unfavourable step	€ 209,606 Profit after taxes 2024: € 209,606 ▲ 66% vs 2023 (€ 126,347) Favourable step	€ 318,941 Profit after taxes 2025: € 318,941 ▲ 52% vs 2024 (€ 209,606) Favourable step	▲ 52%
Equity	€ 619,538 Equity 2022: € 619,538 First fiscal year in the series	€ 620,885 Equity 2023: € 620,885 Unchanged (€ 619,538) Favourable step	€ 625,492 Equity 2024: € 625,492 ▲ 1% vs 2023 (€ 620,885) Favourable step	€ 944,432 Equity 2025: € 944,432 ▲ 51% vs 2024 (€ 625,492) Favourable step	▲ 51%
Total debts	€ 1,616,712 Total debts 2022: € 1,616,712 First fiscal year in the series	€ 1,661,965 Total debts 2023: € 1,661,965 ▲ 3% vs 2022 (€ 1,616,712) Unfavourable step	€ 1,458,266 Total debts 2024: € 1,458,266 ▼ 12% vs 2023 (€ 1,661,965) Favourable step	€ 1,223,910 Total debts 2025: € 1,223,910 ▼ 16% vs 2024 (€ 1,458,266) Favourable step	▼ 16%
Cash	€ 333,541 Cash 2022: € 333,541 First fiscal year in the series	€ 501,658 Cash 2023: € 501,658 ▲ 50% vs 2022 (€ 333,541) Favourable step	€ 327,262 Cash 2024: € 327,262 ▼ 35% vs 2023 (€ 501,658) Unfavourable step	€ 461,853 Cash 2025: € 461,853 ▲ 41% vs 2024 (€ 327,262) Favourable step	▲ 41%
Land & buildings	€ 459,839 Land & buildings 2022: € 459,839 First fiscal year in the series	€ 434,370 Land & buildings 2023: € 434,370 ▼ 6% vs 2022 (€ 459,839) Unchanged	€ 408,901 Land & buildings 2024: € 408,901 ▼ 6% vs 2023 (€ 434,370) Unchanged	€ 383,432 Land & buildings 2025: € 383,432 ▼ 6% vs 2024 (€ 408,901) Unchanged	▼ 6%
Retained profit	€ 557,538 Retained profit 2022: € 557,538 First fiscal year in the series	€ 558,885 Retained profit 2023: € 558,885 Unchanged (€ 557,538) Favourable step	€ 563,492 Retained profit 2024: € 563,492 ▲ 1% vs 2023 (€ 558,885) Favourable step	€ 882,432 Retained profit 2025: € 882,432 ▲ 57% vs 2024 (€ 563,492) Favourable step	▲ 57%
Dividend	€ 100,000 Dividend 2022: € 100,000 First fiscal year in the series	€ 125,000 Dividend 2023: € 125,000 ▲ 25% vs 2022 (€ 100,000) Unchanged	€ 195,000 Dividend 2024: € 195,000 ▲ 56% vs 2023 (€ 125,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 195,000) Unchanged	▼ 100%
Bank debt	€ 1,102,667 Bank debt 2022: € 1,102,667 First fiscal year in the series	€ 961,492 Bank debt 2023: € 961,492 ▼ 13% vs 2022 (€ 1,102,667) Favourable step	€ 821,522 Bank debt 2024: € 821,522 ▼ 15% vs 2023 (€ 961,492) Favourable step	€ 682,420 Bank debt 2025: € 682,420 ▼ 17% vs 2024 (€ 821,522) Favourable step	▼ 17%
Balance sheet total	€ 2,290,126 Balance sheet total 2022: € 2,290,126 First fiscal year in the series	€ 2,336,726 Balance sheet total 2023: € 2,336,726 ▲ 2% vs 2022 (€ 2,290,126) Unchanged	€ 2,137,634 Balance sheet total 2024: € 2,137,634 ▼ 9% vs 2023 (€ 2,336,726) Unchanged	€ 2,222,219 Balance sheet total 2025: € 2,222,219 ▲ 4% vs 2024 (€ 2,137,634) Unchanged	▲ 4%
Employees (FTE)	4.6 Employees (FTE) 2022: 4.6 First fiscal year in the series	5.2 Employees (FTE) 2023: 5.2 ▲ 0.6 vs 2022 (4.6) Unchanged	5.2 Employees (FTE) 2024: 5.2 Unchanged (5.2) Unchanged	5.4 Employees (FTE) 2025: 5.4 ▲ 0.2 vs 2024 (5.2) Unchanged	▲ 0.2

Key figures of OMNIMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to OMNIMED?

What happened at OMNIMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Toon Verpraet BV stepped down as director. NBB
Jul 30, 2026 New annual accounts for financial year 2025: profit of € 318,941 (▲ 52% vs 2024). Source: NBB ↗
Jul 25, 2022 New establishment in Kapellen. KBO
2017 Toon Verpraet BV became a director. NBB
Aug 30, 1999 New establishment in Kalmthout. KBO
Jun 4, 1999 Start of the company according to the CBE. KBO

In short

From € 153,596 profit in 2022 to € 318,941 profit in 2025.

Paid € 256,717 in corporate taxes since 2022.

Best year ever: 2025, with € 318,941 profit.

On average € 187,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Toon Verpraet 100%

The stake of Toon Verpraet comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

OMNIMED

The shares are held by Toon Verpraet (100%).

Directors

According to the 2025 annual accounts

Toon Verpraet BV

Gedelegeerd bestuurder · represented by Toon Verpraet

since 2017 · until 2029

Shareholders

Toon Verpraet

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Heidestatiestraat (Heide) 23 box 1

2920 Kalmthout

2.092.045.421

Heidestatiestraat (Heide) 23/1

2920 Kalmthout

Active since 30 August 1999

2.377.529.584

Kapelsestraat 104

2950 Kapellen

Active since 25 July 2022

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0466.165.667

VAT number

BE 0466.165.667

Registered office

Heidestatiestraat (Heide) 23 bus 1, 2920 Kalmthout

Names & denominations

OMNIMED

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

4 June 1999

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

OMNIMED

Financials

What happened to OMNIMED?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions